Literature DB >> 6133497

Adenosine deaminase complexing protein (ADCP): a transformation sensitive protein with potentials of a cancer marker.

E Herbschleb-Voogt, J Ten Kate, P Meera Khan.   

Abstract

Several observations by independent investigators in the past have indicated that adenosine deaminase complexing protein (ADCP), present in considerable quantities in certain human tissues, was absent or decreased in the cancers originated from them. During the present study, electrophoretic analysis of adenosine deaminase (ADA) isozymes and radioimmunoassay for ADCP in the primary fibroblasts and the transformed as well as certain tumor derived cell lines have demonstrated that ADCP present in large quantities in the primary cells was absent or nearly absent in the transformed or tumor-derived cell lines. Though the mechanisms involved are not yet clear, the above observations indicate that ADCP has the potentials of a useful marker in the studies on transformed cells and cancer tissues.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6133497

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Basic defect in the expression of adenosine deaminase in ADA-SCID disease. II. Deficiency of ADA-CRM detected in heterozygote human-Chinese hamster cell hybrids.

Authors:  E Herbschleb-Voogt; J W Scholten; P Meera Khan
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

2.  Immunohistochemical localization of adenosine deaminase complexing protein in intestinal mucosa and in colorectal adenocarcinoma as a marker for tumour cell heterogeneity.

Authors:  J Ten Kate; J T Wijnen; J Boldewijn; P M Khan; F T Bosman
Journal:  Histochem J       Date:  1985-01

3.  A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells.

Authors:  U V Wesley; A P Albino; S Tiwari; A N Houghton
Journal:  J Exp Med       Date:  1999-08-02       Impact factor: 14.307

Review 4.  Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma.

Authors:  Thomas Bogenrieder; Meenhard Herlyn
Journal:  Crit Rev Oncol Hematol       Date:  2002-10       Impact factor: 6.312

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.